Background: With rising cancer care costs, including high-priced cancer drugs, financial
hardship is increasingly documented among cancer survivors in the United States; research …

Background: Patients with cancer experience financial toxicity from the costs of treatment, as
well as material and psychologic stress related to this burden. A synthesized understanding …

In 2017, the Seventieth World Health Assembly adopted resolution WHA70. 12 on Cancer
prevention and control in the context of an integrated approach (Appendix A). Operative …

BACKGROUND Cancer and its treatment lead to increased financial distress for patients. To
the authors' knowledge, to date, no standardized patient‐reported outcome measure has …

Substantial improvements in survival have been seen in multiple myeloma (MM) over recent
years, associated with the introduction and widespread use of multiple novel agents and …

Patients experiencing financial distress as a side-effect of cancer are not only reported in the
United States, but also in third-party payer healthcare systems in Europe. Since validated …

Background Financial toxicity has traditionally been attributed to the rising costs of cancer
care. As ability to work impacts one's financial situation, limited employment and reduced …

Molecular and immune therapies have revolutionized cancer treatment and improved
patient outcomes and survival. However, the pricing of these drugs has become an issue as …

Abstract Treatment options in multiple myeloma (MM) are increasing with the introduction of
complex multi-novel-agent-based regimens investigated in randomized clinical trials …

Purpose The aim of this study was to examine the relationship between employment and
financial toxicity by examining the prevalence of, and factors associated with, financial …